FANCB and neoplasm: In our study, CBD was fused to the N-terminal of Fab-L using a linker, which indeed enhanced the target of CBD-Fab in vitro and in vivo. CBD-Fab mainly accumulated in tumors and transported into tumor tissues faster than cetuximab due to its smaller molecular weight (Figs 4 and 5).